The Beneficial Effect of Platycodon grandiflorum on DSS-induced Colitis through Regulation of HIF-1α in Mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Ulcerative colitis (UC) is a typical inflammatory colon disorder. Platycodon grandiflorum (PG) is known to exert various beneficial effects including anti-oxidative and anti-bacterial properties and improvements in liver function. However, the improving effect and mechanism of PG on intestinal inflammation are not fully understood. The present research was designed to investigate the effect of PG on the clinical signs of DSS-induced colitis in mice. The ameliorative effects of PG on inflammatory cytokine expression and the activation of hypoxia-inducible-factor (HIF)-1α in DSS-treated colon tissue were also determined. Our results showed that mice treated with DSS displayed the main clinical symptoms of colitis, including weight loss, bloody stools, decrease in colon length and diarrhea and PG treatment significantly improved the clinical features induced by DSS in mice. PG inhibited the increase in the levels of inflammatory cytokines caused by DSS in colon tissues. We also showed that the anti-inflammatory mechanism of PG involved suppressing the activation of HIF-1α in DSS-treated colon tissues. Collectively, the findings of this study indicate the prospect of developing new drugs from PG for UC treatment.
Abstract
Ulcerative colitis (UC) is a typical inflammatory colon disorder. Platycodon grandiflorum (PG) is known to exert various beneficial effects including anti-oxidative and anti-bacterial properties and improvements in liver function. However, the improving effect and mechanism of PG on intestinal inflammation are not fully understood. The present research was designed to investigate the effect of PG on the clinical signs of DSS-induced colitis in mice. The ameliorative effects of PG on inflammatory cytokine expression and the activation of hypoxia-inducible-factor (HIF)-1α in DSS-treated colon tissue were also determined. Our results showed that mice treated with DSS displayed the main clinical symptoms of colitis, including weight loss, bloody stools, decrease in colon length and diarrhea and PG treatment significantly improved the clinical features induced by DSS in mice. PG inhibited the increase in the levels of inflammatory cytokines caused by DSS in colon tissues. We also showed that the anti-inflammatory mechanism of PG involved suppressing the activation of HIF-1α in DSS-treated colon tissues. Collectively, the findings of this study indicate the prospect of developing new drugs from PG for UC treatment.
참고문헌 (27)
- Ardizzone, S., "Biologic therapy for inflammatory bowel disease", Drugs, 65, pp.2253~2286 (2005)
- Baumgart, D. C., "Inflammatory bowel disease : Cause and immunobiology", Lancet, 369, pp.1627~1640 (2007)
- 최장남, "An Investigation of Characteristics of Chinese Bellflower (Platycodon grandiflorum A.) Cultivated Soil", 한국자원식물학회지, 31(6), pp.660~666 (2018), 한국자원식물학회[DOI]
- Cottone, M., "Is 5- ASA still the treatment of choice for ulcerative colitis?", Curr. Drug Targets, 12, pp.1396~1405 (2011)
- Danese, S., "Inflammatory bowel disease; the role of environmental factors", Autoimmun. Rev, 3, pp.394~400 (2004)
- Domenech, E, "Inflammatory bowel disease : Current therapeutic options", Digestion, 73, pp.67~76 (2006)
- Eichele, D. D., "Dextran sodium sulfate colitis murine model : An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis", World J. Gastroenterol, 23, pp.6016~6029 (2017)
- Furuta, G. T., "Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia", J. Exp. Med, 193(9), pp.1027~1034 (2001)
- Glover, L. E., "Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis", Gastroenterology, 140, pp.1748~1755 (2011)
- Hendrickson, B. A., "Clinical aspects and pathophysiology of inflammatory bowel disease", Clin. Microbiol. Rev, 15, pp.79~94 (2002)
- Karhausen, J., "Epithelial hypoxiainducible factor-1 is protective in murine experimental colitis", J. Clin. Investig, 8, pp.1098~1106 (2004)
- Kim, Y. P., "Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum", Planta Med, 67, pp.362~364 (2001)
- Kim Y. S., "Isolation of a new saponin and cytotoxic effect of saponins from the root of Platycodon grandiflorum on human tumor cell lines", Planta Med, 71, pp.566~568 (2005)
- Li, Y., "Diseaserelated expression of the IL-6", STAT3, Gut, pp.2010, 59[DOI]
- Mueller, C, "Tumour necrosis factor in mouse models of chronic intestinal inflammation", Immunology, 105, pp.1~8 (2002)
- Nunes, N. S., "Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis", World J. Gastroenterol, 24(38), pp.4341~4355 (2018)
- Ogata, H., "Cytokine and anti-cytokine therapies for inflammatory bowel disease", Curr. Pharm. Des, 9, pp.1107~1113 (2003)
- Papadakis, K. A., "Role of cytokines in the pathogenesis of inflammatory bowel disease", Annu. Rev. Med, 51, pp.289~298 (2000)
- Park, J. H., "IBD immunopathogenesis : A comprehensive review of inflammatory molecules", Autoimmun. Rev, 16(4), pp.416~426 (2017)
- Park, Y. S., "Platycodon grandiflorum extract represses up-regulated adipocyte fatty acid binding protein triggered by a high fat feeding in obese rats", World J. Gastroenterol, 7, pp.3493~3499 (2007)
- Sandborn, W. J., "Biologic therapy of inflammatory bowel disease", Gastroenterology, 122, pp.1592~1608 (2002)
- Sands, B. E., "The role of TNFalpha in ulcerative colitis", J. Clin. Pharmacol, 47(8), pp.930~941 (2007)
- Scaldaferri, F., "VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis", Gastroenterology, 136, pp.585~595 (2009)
- Taylor, C. T., "Hypoxia and gastrointestinal disease", J. Mol. Med, 85, pp.1295~1300 (2007)
- Van Uden, P., "Regulation of hypoxia-inducible factor-1α by NF-κB", Biochem. J, 412, pp.477~484 (2008)
- Wirtz, S., "Chemically induced mouse models of acute and chronic intestinal inflammation", Nat. Protoc, 12(7), pp.1295~1309 (2017)
- Yashiro, M, "Ulcerative colitis-associated colorectal cancer", World J. Gastroenterol, 28, pp.16389~16397 (2014)